


Urania Therapeutics benefits from €1.7M Deeptech financing from Bpifrance

Domain Therapeutics secures €6 million ($6.7M) debt financing

Alderaan Biotechnology raises €18.5M in Series A from Advent France Biotechnology (AFB) and Medicxi
Advent France Biotechnology participe au tour d’amorçage de 4,2 millions d’euros d’Augustine Therapeutics

Urania Therapeutics closes a €3.5M initial seed round

Provepharm Life Solutions invests €9M in its new pilot production unit

Scintil Photonics raises €4M ($4.4M) in first-round funding

Domain Therapeutics invests in Ermium Therapeutics to develop first-in-class CXCR4 candidate for autoimmune diseases
